Skip to main content
SpringerLink
Log in

Kardiale Nebenwirkungen trizyklischer Antidepressiva

  • Conference paper
Book cover Differenzierte Therapie mit trizyklischen Antidepressiva

  • 59 Accesses

Zusammenfassung

Seit mehr als 30 Jahren sind trizyklische Antidepressiva (TZA) im klinischen Gebrauch und haben sich als effektive Substanzen in der Behandlung von Depression und depressiver Begleitsymptome anderer psychischer Erkrankungen erwiesen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alexander CS (1968) Cardiotoxic effects of phenothiazine and related drugs. Circulation 38:1014–1015

    PubMed  CAS  Google Scholar 

  2. Alexander CS, Nino A (1969) Cardiovascular complications in young patients taking psychotropic drugs. Am Heart J 78:757–769

    Article  PubMed  CAS  Google Scholar 

  3. Asberg M, Cronholm B, Sjöquist F (1979) Relationship between plasmalevel and therapeutic effect of nortriptyline. Br Med J 3:331–334

    Article  Google Scholar 

  4. Auclair MC, Guida P, Lechant P (1969) Analyse der elektrophysiologischen Wirkung von Imipramin auf eine Herzmukselfaser. Arch Inter Pharmacodyn Ther 181:218–231

    CAS  Google Scholar 

  5. Barnes RJ, Kong SM, Wu RWY (1968) Electrocardiographic changes in amitriptyline poisoning. Br Med J 3:222–223

    Article  PubMed  CAS  Google Scholar 

  6. Bigger TJ Jr, Giardina EGV, Perel JM (1977) Cardiac antiarrhythmic effect of imipramine-hydrochlorid. N Engl J Med 296:206–208

    Article  PubMed  CAS  Google Scholar 

  7. Boehnert MT, Lovejoy FH Jr (1985) Value von QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 313:474–479

    Article  PubMed  CAS  Google Scholar 

  8. Boissier JR, Simon P, Witchitz S (1965) Kardiotoxische Effekte von Imipramin und Amitri-tylin und deren Monodesmethyl-Metaboliten auf das Meerschweinchen. Therapie 20:67–75

    CAS  Google Scholar 

  9. Bojanowsky J, Tölle R (1974) Dihydroergotamin gegen die Kreislaufwirkung der Thymo-leptika. Dtsch Med Wochenschr 99:1064–1069

    Article  Google Scholar 

  10. Borchard F (1987) Autonomie und Histochemie der autonomen Herznerven. In: Brisse B, Bender F (Hrsg) Autonome Innervation des Herzens. Steinkopf, Darmstadt, S 1–16

    Chapter  Google Scholar 

  11. Boston Collaborative Drug Surveillance Program (1971) Adverse reactions to the tricyclic antidepressant drugs. Lancet 2:529–531

    Google Scholar 

  12. Breyer-Pfaff U (1987) Pharmakologische Wirkung synthetischer Antidepressiva beim Tier. In: Breyer-Pfaff U, Gärtner HJ (Hrsg) Antidepressiva. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 81–130

    Google Scholar 

  13. Burckhardt D, Fleischhauer HJ, Müller V, Neubauer HW (1976) Beitrag zur Wirkung tri-und tetrazyklischer Antidepressiva auf Herz und Kreislauf. Schweiz Med Wochenschr 106:1896–1903

    PubMed  CAS  Google Scholar 

  14. Burckhardt D, Raeder E, Müller V, Imhof P, Neubauer H (1978) Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA 239:213–216

    Article  PubMed  CAS  Google Scholar 

  15. CAPS (1988) Effects of encainid, flecainid, imipramine and moricizine on ventricular arrhythmia during the year after acute myocardial infarction: The CAPS. Am J Cardiol 61:501–509

    Google Scholar 

  16. Cassen N (1982) Cardiovascular effects of antidepressants. J Clin Psychiatry 43:22–28

    Google Scholar 

  17. Coull DC, Crooks J, Dingwall-Fordyce I, Scott AM, Weir RD (1970) Amitriptyline and cardiac disease — risk of sudden death identified by monitoring system. Lancet 2:590–591

    Article  PubMed  CAS  Google Scholar 

  18. Coumel P, Leclercq JF, Dessertenne F (1984) Torsades de pointes. In: Josephson ME, Wellens HJJ (eds) Tachycardias: mechanism, diagnosis, treatment. Lea & Febiger, Philadelphia, pp 325–351

    Google Scholar 

  19. Davisen ET (1985) Amitriptyline-induced Torsade de pointes. Successfully therapy with atrial pacing. J Electrocardiol 18/3:299–301

    Article  Google Scholar 

  20. Dietch JT, Fine M (1980) The effect of nortriptyline in elderly patients with cardiac conduction disease. J Clin Psychiatry 51:65–67

    Google Scholar 

  21. Dominiak P, Türck D, Fuchs G (1987) Sympathische Regulationsmechanismen ausschließlich adrenerger Rezeptoren. In: Brisse B, Bender F (Hrsg) Autonome Innervation des Herzens. Steinkopf, Darmstadt, S 17–36

    Chapter  Google Scholar 

  22. Freeman JW, Mundy GR, Beattie RR, Ryan C (1969) Cardiac abnormalities in poisoning with tricyclic antidepressants. Br Med J 2:610–611

    Article  PubMed  CAS  Google Scholar 

  23. Freyschuss U, Sjöquist F, Tuck D, Asberg M (1970) Circulatory effects in man of nortriptyline, a tricyclic antidepressant drug. Pharmacol Clin 2:68–71

    Article  Google Scholar 

  24. Giardina EGV, Barnard T, Johnsen LL, Saroff AL, Bigger JT Jr, Louie M (1986) the antiarrhythmic effect of nortriptyline in cardiac patients with ventricular premature depolari-sations. J Am Coll Cardiol 7:1363–1369

    Article  PubMed  CAS  Google Scholar 

  25. Giardina EGV, Bigger JT Jr, Glassman AH (1979) The electrocardiographic and antiarrhythmic effects of imipramine hydrochlorid at therapeutic plasma concentrations. Circulation 60:1045–1052

    PubMed  CAS  Google Scholar 

  26. Giardina EGV, Johnsen LL, Vita J, Bigger TJ Jr, Brem RF (1985) Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias. Am Heart J 109:992

    Article  PubMed  CAS  Google Scholar 

  27. Glassman AH (1981) Herzfunktions- und Blutdruckmessungen bei Patienten vor und nach Verabreichung von Antidepressiva. In: Müller-Oerlinghaus B (Hrsg) Klinische Relevanz der Kardiotoxizität von Psychopharmaka. Pmipharm & Medical Inform, Frankfurt/M, S 7–17

    Google Scholar 

  28. Glassman AH (1984) The newer antidepressant drugs and their cardiovascular effects. Psychopharmacol Bull 20/2:272

    PubMed  CAS  Google Scholar 

  29. Glassman AH, Bigger TJ Jr, Giardini EGV (1979) Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1:468–472

    Article  PubMed  CAS  Google Scholar 

  30. Glassman AH, Johnson LL, Giardina EGV, Walsh BT, Roose SP, Cooper TB, Bigger TJ Jr (1983) The use of imipramine in depressed patients with congestive heart failure. JAMA 250:1997–2001

    Article  PubMed  CAS  Google Scholar 

  31. Glassman AH, Walsh BT, Roose SP, Rosenfeld R, Bruno RL, Bigger TJ Jr, Giardina EGV (1982) Factors related to orthostatic hypotension associated with tricyclic antidepressants. J Clin Psychiatry 43/5:35

    PubMed  CAS  Google Scholar 

  32. Goldberg RJ, Capone RJ, Hunt JD (1985) Cardiac complications following tricyclic antidepressant overdose. JAMA 254:1772–1775

    Article  PubMed  CAS  Google Scholar 

  33. Hartling OJ, Marning J, Kindsen P, Dahl A, Hoilud-Carlsen PF, Hartling L (1987) The effect of the tricyclic antidepressant drug nortriptyline on left ventricular ejection fraction and left ventricular volumes. Psychopharmacology 91:381–383

    Article  PubMed  CAS  Google Scholar 

  34. Hayes JR, Born GF, Rosenbaum AM (1977) Incidence of orthostatic hypotension in primary affective disorder treated with tricyclic antidepressants. Mayo Clin Proc 52:509

    PubMed  CAS  Google Scholar 

  35. Jefferson JW (1989) Cardiovascular effects and toxicity of anxiolytics and antidepressants. J Clin Psychiatry 50:368–378

    PubMed  CAS  Google Scholar 

  36. Kantor SJ, Bigger JT Jr, Glassman AH (1975) Imipramine induced heartblock. A longitudinal case study. JAMA 231:1364–1366

    Article  PubMed  CAS  Google Scholar 

  37. Kantor SJ, Glassman AH, Bigger JT Jr (1978) The cardiac effects of therapeutic plasma concentrations of imipramine. Am J Psychiatry 135:534–538

    PubMed  CAS  Google Scholar 

  38. Krikler DM, Curry PVL (1976) Torsade de pointes, an atypical ventricular tachycardia. Br Heart J 38:117–120

    Article  PubMed  CAS  Google Scholar 

  39. Kristiansen ES (1961) Cardiac complications during treatment with imipramine (Tofranil). Acta Pschiatr Neurol Scand 36:427–442

    Article  CAS  Google Scholar 

  40. Madahasira S (1986) Cardiac antiarrhythmic effect of nortriptyline. Gen Hosp Psychiatry 8:123–125

    Article  Google Scholar 

  41. Masters AB (1967) Delayed death in imipramine poisoning. Br Med J 3:866–867

    Article  PubMed  CAS  Google Scholar 

  42. Moccetti T, Lichtlen P (1971) Herzveränderungen nach Phenothiazinen und Imipramin-abkömmlingen. Dtsch Med Wochenschr 96:1089–1091

    Article  PubMed  CAS  Google Scholar 

  43. Moir DC, Crooks J, Cornwall WB, O’Malley K, Dingwall-Fordyce I, Turnbull MJ, Weir RD (1972) Cardiotoxicity of amitriptyline. Lancet 2:561–564

    Article  PubMed  CAS  Google Scholar 

  44. Müller V, Burckhardt D (1974) Die Wirkung tri- und tetrazyklischer Antidepressiva auf Herz und Kreislauf. Schweiz Med Wochenschr 104:1911–1913

    PubMed  Google Scholar 

  45. Mueller OE, Goodman N, Bellett S (1961) The hypotensive effect of imipramine hydrochlorid in patients with cardiovascular disease. Clin Pharmacol Ther 2:300–307

    Google Scholar 

  46. Mutschler E (1981) Pharmakon Rezeptor Wechselwirkungen. In: Mutschler E (Hrsg) Arzneimittelwirkungen, 4. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 46–54

    Google Scholar 

  47. Mutschler E (1981) Am Sympathicus angreifende Substanzen. In: Mutschler E (Hrsg) Arzneimittelwirkungen, 4. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 242–265

    Google Scholar 

  48. Nieman JT, Bessen HA, Rosenstein RJ, Laks MM (1986) Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 57:1154–1159

    Article  Google Scholar 

  49. Nobel J, Matthew H (1969) Acute poisoning by tricyclic antidepressants: clinical features and management of 100 patients. Clin Toxicol 2:403

    Article  Google Scholar 

  50. Rasmussen EB, Kristiansen P (1963) ECG changes during amitriptyline treatment. Am J Psychiatry 119:781–782

    PubMed  CAS  Google Scholar 

  51. Rawling DA, Fozzard HA (1979) Effecs of imipramine on cellular electrophysiological properties of cardiac purkinje fibers. J Pharmacol Exp Ther 209:371–375

    PubMed  CAS  Google Scholar 

  52. Reed K, Smith MC, Scholar JC (1980) Cardiovascular effects of nortriptyline in geriatric patients. Am J Psychiatry 137:986–988

    PubMed  CAS  Google Scholar 

  53. Richardsen HL, Graupner KE, Richardsen ME (1966) Intramyocardial lesions in patients dying suddenly and unexpectedly. JAMA 195:254–260

    Article  Google Scholar 

  54. Roose SP, Glassman AH, Giardina EGV, Johnsen LL, Walsh BT, Woodring S, Bigger TJ Jr (1986) Nortriptyline in depressed patients with left ventricular impairment. JAMA 256:3253–3257

    Article  PubMed  CAS  Google Scholar 

  55. Roose SP, Glassman AH, Giardina EGV, Walsh BT, Woodring S, Bigger JT Jr (1987) Tricyclic antidepressive drugs in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44:273–275

    PubMed  CAS  Google Scholar 

  56. Rosen PB (1960) Case report of auricular fibrillation following the use of imipramine (Tofranil). J Mount Sinai Hosp 27:609–611

    CAS  Google Scholar 

  57. Sacks MH, Bonforte J, Lasser RR, Dimich I (1968) Cardiovascular complications of imipramine intoxication. JAMA 205:588–590

    Article  PubMed  CAS  Google Scholar 

  58. Schneider LS, Sloane RB, Staples FR, Bender M (1986) Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psycho-pharmacol Vol 6/3:172–176

    CAS  Google Scholar 

  59. Schou M (1962) Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type. Acta Psychiatr Scand Suppl 38:331–336

    Article  Google Scholar 

  60. Sedal L, Korman MG, Williams PO, Mushin G (1972) Overdosage of tricyclic antidepressants: a report of two deaths and a prospective study of 24 patients. Med J Aust 2:74–79

    PubMed  CAS  Google Scholar 

  61. Sloman C (1960) Myocardial infarction during imipramine treatment of depression. Can Med Assoc J 82:20–22

    PubMed  CAS  Google Scholar 

  62. Smith RB, Rusbatch BJ (1967) Amitriptyline and heartblock. Br J Med 3:311

    CAS  Google Scholar 

  63. Stannard M, Caplan HL (1967) Cardiac arrest due to imipramine hydrochlorid. Med J Aust 84:22–24

    Google Scholar 

  64. Taylor DJE, Braithwaite RA (1978) Cardiac effects of tricyclic antidepressants medication. A preliminary study of nortriptyline. Br Heart J 40:1005–1009

    Article  PubMed  CAS  Google Scholar 

  65. Thayssen P, Bjerre M, Kragh-Sorensen P, Petersen OL, Kristiansen CB, Gram LF (1981) Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharma-cology 74:360–364

    Article  CAS  Google Scholar 

  66. Thorstrand C (1974) Cardiovascular effects of poisoning with tricyclic antidepressants. Acta Med Scand 195:505–514

    Article  PubMed  CAS  Google Scholar 

  67. Veith RC, Ruskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306:954–959

    Article  PubMed  CAS  Google Scholar 

  68. Vieweg WVR, Yazel JJ, Ballenger JC (1984) Tricyclic antidepressant use in a patient with bundle branch block and ventricular ectopy. J Clin Psychiatry 45:353

    PubMed  CAS  Google Scholar 

  69. Vohra J, Burrows G, Hunt D (1975) The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on cardiac conduction. Eur J Cardiol 3:219–227

    PubMed  CAS  Google Scholar 

  70. Weissler AM, Harris WS, Schomfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37:149–159

    PubMed  CAS  Google Scholar 

  71. Wexler BC, Kittinger GW, Judd JT (1967) Response to drug induced myocardial necrosis in rats with various degrees of arterosclerosis. Circ Res 20:78–87

    PubMed  CAS  Google Scholar 

  72. Williams RB, Sherter C (1971) Cardiac complications of tricyclic antidepressant therapy. Am Intern Med 74:395–398

    Google Scholar 

  73. Zbinden G, Ettlin R, Bachmann E (1980) Electrocardiographic changes in rats during chronic treatment with antidepressant and neuroleptic drugs. Arzneimittelforschung 30:1709–1715

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. I. Szendey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Günthner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany

    Burkhard Pflug

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Szendey, I., Günthner, A. (1994). Kardiale Nebenwirkungen trizyklischer Antidepressiva. In: Pflug, B. (eds) Differenzierte Therapie mit trizyklischen Antidepressiva. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77887-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77887-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56129-3

  • Online ISBN: 978-3-642-77887-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation